ICD Co., Ltd.

KOSDAQ:A040910 Stock Report

Market Cap: ₩102.6b

ICD Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for ICD.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Semiconductor earnings growth35.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article • Feb 09

We Think ICD (KOSDAQ:040910) Has A Fair Chunk Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Sep 18

Is ICD (KOSDAQ:040910) Using Debt In A Risky Way?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Aug 13

Insufficient Growth At ICD Co., Ltd. (KOSDAQ:040910) Hampers Share Price

KOSDAQ:A040910 1 Year Share Price vs Fair Value Explore ICD's Fair Values from the Community and select yours When you...
Analysis Article • Mar 21

Why Investors Shouldn't Be Surprised By ICD Co., Ltd.'s (KOSDAQ:040910) 25% Share Price Plunge

ICD Co., Ltd. ( KOSDAQ:040910 ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...
Analysis Article • Feb 11

Here's Why ICD (KOSDAQ:040910) Can Afford Some Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Nov 29

ICD Co., Ltd. (KOSDAQ:040910) Investors Are Less Pessimistic Than Expected

With a median price-to-sales (or "P/S") ratio of close to 1.1x in the Semiconductor industry in Korea, you could be...
Analysis Article • Oct 24

Does ICD (KOSDAQ:040910) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • Aug 22

Risks To Shareholder Returns Are Elevated At These Prices For ICD Co., Ltd. (KOSDAQ:040910)

With a median price-to-sales (or "P/S") ratio of close to 1.6x in the Semiconductor industry in Korea, you could be...
Analysis Article • Apr 08

ICD Co., Ltd.'s (KOSDAQ:040910) 47% Price Boost Is Out Of Tune With Revenues

ICD Co., Ltd. ( KOSDAQ:040910 ) shares have had a really impressive month, gaining 47% after a shaky period beforehand...
Analysis Article • Apr 08

The Attractive Combination That Could Earn ICD Co., Ltd. (KOSDAQ:040910) A Place In Your Dividend Portfolio

Is ICD Co., Ltd. ( KOSDAQ:040910 ) a good dividend stock? How can we tell? Dividend paying companies with growing...
Analysis Article • Mar 13

ICD (KOSDAQ:040910) Could Easily Take On More Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Feb 28

When Should You Buy ICD Co., Ltd. (KOSDAQ:040910)?

While ICD Co., Ltd. ( KOSDAQ:040910 ) might not be the most widely known stock at the moment, it saw a decent share...
Analysis Article • Feb 14

If You Like EPS Growth Then Check Out ICD (KOSDAQ:040910) Before It's Too Late

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Analysis Article • Feb 01

Are Robust Financials Driving The Recent Rally In ICD Co., Ltd.'s (KOSDAQ:040910) Stock?

Most readers would already be aware that ICD's (KOSDAQ:040910) stock increased significantly by 17% over the past three...
Analysis Article • Jan 19

Under The Bonnet, ICD's (KOSDAQ:040910) Returns Look Impressive

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Analysis Article • Jan 06

Is ICD Co., Ltd. (KOSDAQ:040910) An Attractive Dividend Stock?

Is ICD Co., Ltd. ( KOSDAQ:040910 ) a good dividend stock? How can we tell? Dividend paying companies with growing...
Analysis Article • Dec 24

Be Sure To Check Out ICD Co., Ltd. (KOSDAQ:040910) Before It Goes Ex-Dividend

It looks like ICD Co., Ltd. ( KOSDAQ:040910 ) is about to go ex-dividend in the next three days. Investors can purchase...
Analysis Article • Dec 13

Is ICD's (KOSDAQ:040910) Share Price Gain Of 142% Well Earned?

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Analysis Article • Nov 30

We Think ICD (KOSDAQ:040910) Can Manage Its Debt With Ease

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICD has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A040910 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025197,041-1,9037,6258,008N/A
9/30/2025207,325-24,58410,24411,356N/A
6/30/2025197,400-25,66013,02213,917N/A
3/31/2025148,136-30,931-17,575-16,939N/A
12/31/2024147,616-28,291-31,126-27,814N/A
9/30/2024105,204-26,968-8,269-5,759N/A
6/30/202497,848-34,933-19,496-14,150N/A
3/31/202469,774-34,374-23,326-15,855N/A
12/31/202362,274-41,318-7,641-1,470N/A
9/30/202376,827-39,043-30,828-21,947N/A
6/30/2023110,543-25,056-17,023-7,278N/A
3/31/2023149,043-13,433-18,948-8,966N/A
12/31/2022150,945-5,419-23,621-14,294N/A
9/30/2022136,0636,018-9,696-2,454N/A
6/30/2022106,2051,751-12,820-7,534N/A
3/31/2022103,384-4,692-17,521-14,162N/A
12/31/2021115,76976216,68021,230N/A
9/30/2021152,326-3,38735,00639,655N/A
6/30/2021256,82417,00165,58569,605N/A
3/31/2021286,42628,30367,60371,527N/A
12/31/2020308,96533,45946,52549,530N/A
9/30/2020297,36846,44816,51319,177N/A
6/30/2020195,69331,912-11,974-10,056N/A
3/31/2020133,70217,3971,5383,688N/A
12/31/2019121,60511,15220,70523,966N/A
9/30/2019136,11918,890N/A43,434N/A
6/30/2019149,36814,340N/A33,972N/A
3/31/2019194,56516,102N/A46,625N/A
12/31/2018233,97529,834N/A29,835N/A
9/30/2018285,28526,393N/A-3,079N/A
6/30/2018324,86330,425N/A14,616N/A
3/31/2018267,97731,296N/A-10,007N/A
12/31/2017311,84824,491N/A-11,884N/A
9/30/2017272,22016,792N/A2,109N/A
6/30/2017272,68617,245N/A-4,378N/A
3/31/2017328,38718,684N/A-14,771N/A
12/31/2016230,90910,354N/A-9,108N/A
12/31/201572,0615,413N/A8,817N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A040910's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A040910's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A040910's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A040910's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A040910's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A040910's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/09 16:40
End of Day Share Price 2026/05/08 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ICD Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Choi Soon-HoEugene Investment & Securities Co Ltd.
Dae Jong NamiM Securities
Jong Woo YooKorea Investment & Securities Co., Ltd.